Xuheng Bio

Xuheng Bio

普珩生物

Xuheng Bio

Biotech/Healthcare

Xuheng Bio is a tumor cell immunotherapy service provider. It owns GMP-grade virus production and GMP-grade cell production facilities, providing users with products and services including novel tumor acidic microenvironment-activated CAR-T products and chimeric antigen receptor (CAR)-T cell…

Latest round: Series A (2018)

Source: ChinaBulls — chinabulls.com

Last updated 2018-02-01

Funding history

Request access to view this section.

Investors

Request access to view this section.

HQ & website

Request access to view this section.

Tags

Request access to view this section.